These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 534518)

  • 1. Structure--activity relationship of inhibitors of hydroxyapatite formation.
    Williams G; Sallis JD
    Biochem J; 1979 Oct; 184(1):181-4. PubMed ID: 534518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation.
    Williams G; Sallis JD
    Calcif Tissue Int; 1982 Mar; 34(2):169-77. PubMed ID: 6282411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inhibition of Herpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate.
    Goodrich JM; Lee KW; Hinze HC
    Arch Virol; 1980; 66(3):261-4. PubMed ID: 6449917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate.
    Reno JM; Lee LF; Boezi JA
    Antimicrob Agents Chemother; 1978 Feb; 13(2):188-92. PubMed ID: 206200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trisodium phosphonoformate, a new antiviral compound.
    Helgstrand E; Eriksson B; Johansson NG; Lannerö B; Larsson A; Misiorny A; Norén JO; Sjöberg B; Stenberg K; Stening G; Stridh S; Oberg B
    Science; 1978 Sep; 201(4358):819-21. PubMed ID: 210500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental studies on the antiherpetic agent phosphonoformic acid.
    Helgstrand E; Oberg B; Alenius S
    Adv Ophthalmol; 1979; 38():276-80. PubMed ID: 230720
    [No Abstract]   [Full Text] [Related]  

  • 7. Observations on the phosphonoformic acid inhibition of RNA dependent DNA polymerases.
    Modak MJ; Srivastava A; Gillerman E
    Biochem Biophys Res Commun; 1980 Sep; 96(2):931-8. PubMed ID: 6158948
    [No Abstract]   [Full Text] [Related]  

  • 8. The synthesis and characterization of N-sulfo-2-amino tricarballylate: an analog of phosphocitrate and inhibitor of calcification.
    Brown MR; Sallis JD
    Anal Biochem; 1983 Jul; 132(1):115-23. PubMed ID: 6312833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrophosphate, phosphate ion interaction: effects on calcium pyrophosphate and calcium hydroxyapatite crystal formation in aqueous solutions.
    Cheng PT; Pritzker KP
    J Rheumatol; 1983 Oct; 10(5):769-77. PubMed ID: 6315937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of phosphocitric acid, a potent inhibitor of hydroxylapatite crystal growth.
    Tew WP; Mahle C; Benavides J; Howard JE; Lehninger AL
    Biochemistry; 1980 Apr; 19(9):1983-8. PubMed ID: 7378389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of herpesvirus and human DNA polymerases by alpha-halogenated phosphonoacetates.
    McKenna CE; Khawli LA; Bapat A; Harutunian V; Cheng YC
    Biochem Pharmacol; 1987 Oct; 36(19):3103-6. PubMed ID: 3663227
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of cytomegalovirus late antigens by phosphonoformate.
    Wahren B; Oberg B
    Intervirology; 1980; 12(6):335-9. PubMed ID: 6244238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiviral activity of phosphonoacetic acid, phosphonopropionic acid, and trisodium phosphonoformate hexahydrate against herpesvirus hominis type 1 and type 2 in vitro].
    Thiel KD; Wutzler P; Sprössig M; Bertram D
    Pharmazie; 1982 Aug; 37(8):608. PubMed ID: 6292963
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of sodium phosphonoformate on blood group antibody detection.
    Douglas R
    Vox Sang; 1987; 53(1):61. PubMed ID: 2958968
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of phosphocitrate and N-sulpho-2-amino tricarballylate, a new analogue of phosphocitrate, in blocking hydroxyapatite induced crystal growth and calcium accumulation by matrix vesicles.
    Shankar R; Brown MR; Wong LK; Sallis JD
    Experientia; 1984 Mar; 40(3):265-7. PubMed ID: 6321227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycochenodeoxycholic acid inhibits calcium phosphate precipitation in vitro by preventing the transformation of amorphous calcium phosphate to calcium hydroxyapatite.
    Qiu SM; Wen G; Hirakawa N; Soloway RD; Hong NK; Crowther RS
    J Clin Invest; 1991 Oct; 88(4):1265-71. PubMed ID: 1655828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of eucaryotic DNA polymerases by phosphonoacetate and phosphonoformate.
    Sabourin CL; Reno JM; Boezi JA
    Arch Biochem Biophys; 1978 Apr; 187(1):96-101. PubMed ID: 655729
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of bile salts with calcium hydroxyapatite: inhibitors of apatite formation exhibit high-affinity premicellar binding.
    Qiu SM; Soloway RD; Crowther RS
    Hepatology; 1992 Nov; 16(5):1280-9. PubMed ID: 1330869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphonoformate inhibits reverse transcriptase.
    Sundquist B; Oberg B
    J Gen Virol; 1979 Nov; 45(2):273-81. PubMed ID: 94344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of phosphaturia elicited by administration of phosphonoformate in vivo.
    VanScoy M; Loghman-Adham M; Onsgard M; Szczepanska-Konkel M; Homma S; Knox FG; Dousa TP
    Am J Physiol; 1988 Nov; 255(5 Pt 2):F984-94. PubMed ID: 2847555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.